SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Korea
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

DAEWOONG CO.,LTD.

Main Activities: Management of Companies and Enterprises

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
DAEWOONG CO.,LTD.

Headquarters
223-23, SANGDAEWON 1-DONG, SEONGNAM-SI JUNGWON-GU, GYEONGGI-DO; Seongnam; Gyeonggi; 462807
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Financial Auditors: Deloitte Touche Tohmatsu (2011)
Incorporation Date: January 10, 1961
Total Employees: 264

Tel: 031-741-7700

Company Description

The firm reached KRW 23.3 billion in sales with service income and commission income by subsidiaries including Daewoong Pharm., Daewoong Bio and Daewoong Development, which operate medical supplies manufacturing.The firm reached KRW 5.8 billion in net profit during the current half year period through biz revenue growth and financial income including interest income, despite heavier cost burden due to increase in expenses for research and development of cancer medicine.The firm is forecast to maintain
More

Company Analysis

According to the Individual - Audited financial statement for the first half of 2012, total net operating revenues increased with 4.49%, from KRW 23,349,731 thousands to KRW 24,397,865 thousands. Operating result increased from KRW 7,569,747 thousands to KRW 8,286,845 thousands which means 9.47% change. The results of the period increased 206.55% reaching KRW 17,884,361 thousands at the end of the period against KRW 5,834,154 thousands last year. Return on equity (Net income/Total equity) went from 2.16% to 6.33%, the Return On Asset (Net income / Total Asset) went from 2.06% to 5.94% and the Net Profit Margin (Net Income/Net Sales) went from 24.99% to 73.30% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 6.62% compared to 4.83% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.52 to 6.67 when compared to the previous year.

Key Executives

Jeong,Nan Yeong President
Lee,Gi Won President
Jang,In Jin Non-Executive Independent Director
Lee,Jung Hun Non-Executive Independent Director
Baek,Mun Gyu Auditor
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

303,932,331

301,170,831

Current Assets

26,959,954

24,436,833

Total Liabilities

17,393,672

18,705,203

Shareholders Equity

286,538,659

282,465,628

Current Liabilities

3,482,012

3,661,411

* All the accounts are in KRW.
Income Statement

Total Operating Revenue

44,303,202

24,397,865

Operational Profit (Loss)

12,043,216

8,286,845

Net Profit (Loss)

21,783,130

17,884,361

* All the accounts are in KRW.
Ratios
Profitability Ratios

Return on Assets (ROA)

7.17%

5.94%

Return on Equity (ROE)

7.6%

6.33%

Return on Sales (ROS)

49.17%

73.3%

Return on Capital

7.25%

6.01%

Gross Profit Margin

88.85%

89.54%

Efficiency Ratios

Current asset turnover

1.64x

1.00x

Asset Turnover

0.15x

0.08x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

20,118,404

16,288,984

EBITDA

12,093,454

8,310,704

Bookvalue (BV)

285,628,155

281,609,739

Liquidity Ratios

Current Ratio

774.26%

667.42%

Quick ratio

774.26%

667.42%

Doom's day ratio

750.72%

515.63%

Cash Flow to Debt

84.13%

39.42%

Leverage Ratios

Leverage ratio

106.07%

106.62%

Debt to equity

6.07%

6.62%

Debt to total assets

5.72%

6.21%

Long Term Debt to Capital

4.63%

5.06%

Market ratios

Price/Book Ratio

0.92

0.64

Trend Ratios

Revenue Trend

97.41%

104.49%

Net Income Trend

225.42%

306.55%